All Comments by Peter Davies
Go to another page:
- 1
- 2
- Tau Aggregates Awaken Genetic Relics in the Brain
- Post-Brexit U.K. Picks Belgian to Run Its Flagship Dementia Research Institute
- Inventory of Tau Modifications Hints at Undiscovered Functions
- Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.
- Mechanistic basis of phenothiazine-driven inhibition of tau aggregation.
- Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.
- NIH Director Announces $100M Prevention Trial of Genentech Antibody
- Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.
- A Tribute to Robert Katzman
- Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
- Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
- We Are What We Consume? Foods, Drugs Affect Amyloid, AD
- Can Travel, Will Deposit: Aβ via the Perforant Pathway?
- Spinal Taps for Tau Tests
- Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.